arrow
K

Kohei Taniguchi

osaka medical and pharmaceutical university
H指数:31
被引数:3,538

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in ER-Positive HER2-Negative Breast Cancer

ASO可视化摘要:ESR1表达与免疫细胞浸润及对免疫检查点抑制剂的应答呈负相关,见于ER阳性HER2阴性乳腺癌。

2025-10-220
PRE
ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2– Breast Cancer: A New Role for ESR1?

ASO作者反思:ER+/HER2–乳腺癌中免疫检查点抑制剂反应的预测因子:ESR1的新作用?

2025-09-170
PRE
ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer

ESR1表达与免疫细胞浸润及对免疫检查点抑制剂的应答呈负相关,见于雌激素受体阳性/HER2阴性乳腺癌。

2025-09-160
PRE
Wnt/β-Catenin-Activated Nonpilomatrical Carcinoma of the Skin: A Case Series
2024-11-010
PRE
Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma
2024-09-170
OAAI
Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node Biopsy

微创根治性子宫切除术和前哨淋巴结活检对早期宫颈癌患者肿瘤学预后的影响

2024-07-080
OAAI
Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience
2024-05-060
OAAI